Cell viability assay demonstrated dramatic effects of CBD, especially, in a combination with inhibitors of NF-κB and PI3K-AKT signaling pathways on GBM cell survival, while an additional effect of SB203580 (alone) or in combination with CBD for GBM survival was relatively modest (Fig. 8c). The gene discussed is NFKB1; the disease is glioblastoma.